GPX1P1: A Promising Drug Target (G441481)

Target Name: GPX1P1

NCBI ID: G441481

GPX1P1

Other Name(s): GPXP1 | GPXL2 | Glutathione peroxidase pseudogene 1 | GPXL1 | glutathione peroxidase pseudogene 1

GPX1P1: A Promising Drug Target

GPX1P1, also known as GPXP1, is a gene that encodes a protein known as GPX1P1. GPX1P1 is a member of the G protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a key role in cellular signaling Members of the GPCR family include many known drug targets, such as prostate cancer, breast cancer, diabetes, and Alzheimer's disease.

The protein encoded by the GPX1P1 gene is an isomer whose N-terminus contains an 伪-helix, a secondary structure commonly found in members of the GPCR family. In addition, the C-terminus of GPX1P1 also contains an 伪-helix, which is the main three-dimensional structure of GPX1P1. However, one significant difference between GPX1P1 and other GPCR family members is its intracellular domain. These intracellular domains usually contain a long linear structure containing an 伪-helix, a 尾-coil, and a 纬-helix. In addition, the intracellular region of GPX1P1 also contains a modified 伪-helix, a unique structure that appears to be different from other GPCR family members.

The function of GPX1P1 is being intensively studied, especially in relation to neurological diseases. Research shows that GPX1P1 plays an important role in the nervous system, especially in the process of neuronal proliferation and apoptosis. For example, studies have shown that GPX1P1 plays a role in neuronal apoptosis and may be involved in an increased risk of depression. In addition, GPX1P1 is also related to the pathogenesis of Parkinson's disease and may play an important role in the pathogenesis of Parkinson's disease.

In addition, GPX1P1 has also been used as a therapeutic drug target. Currently, GPX1P1 has become the subject of research for many drugs, including drugs to treat Parkinson's disease and drugs to treat diabetes. For example, a variety of drugs targeting GPX1P1 have been developed, including traditional Chinese medicine, Western medicine, and biological agents. These drugs have achieved good results in clinical trials, especially in improving motor function in patients with Parkinson's disease and reducing blood sugar levels in patients with diabetes.

Overall, GPX1P1 is a very promising drug target, and its in-depth research is of great significance for the treatment of diseases such as Parkinson's disease and diabetes. With the continuous development of science and technology, people will continue to explore the role of GPX1P1 in drugs and provide more effective treatments for it.

Protein Name: Glutathione Peroxidase Pseudogene 1

The "GPX1P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPX1P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets